MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 1.6% of their position (2.21K shares) of NATERA, INC. on the open market
Open‑market sale worth $569.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/30/2026ACC: 0002010019-26-000021
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
-2.21K
Net shares
Net seller
$569.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.01K
Price / share
$260.49
Trade value
$263.10K
% of position
0.8%
7/27/2026
134.64K→133.63K
Common Stock
Direct
Shares
−1.20K
Price / share
$254.07
Trade value
$305.90K
% of position
0.9%
7/28/2026
133.63K→132.43K
Total
Net shares
−2.21K
Net value
-$569K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/27/2026 | S · Sale | −1.01K | $260.49 | $263.10K | 0.8% | 134.64K | 133.63K |
| Common Stock Direct | 7/28/2026 | S · Sale | −1.20K | $254.07 | $305.90K | 0.9% | 133.63K | 132.43K |
| Total | −2.21K | -$569K | ||||||
Derivative Transactions0
No derivative transactions reported